Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Clues For Brain Cancer Treatment Found At The ESRF

05.04.2004


A team of researchers from the University Hospital of Grenoble (CHU – Inserm U647) and the ESRF1 has found a new treatment that improves the survival of rats with high-grade gliomas.



This research was carried out at the ESRF Medical Beamline. It showed that after a year of this treatment, three rats out of 10 were considered cured, whereas without treatment, all would be dead. The results have just been published in the scientific journal Cancer Research. A glioma is one of the most frequent brain tumours in human adults, and it is not curable. Clinical trials on humans are planned for the near future.

Today, the median survival for patients with glioma is less than a year. Around 5 to 10 adults out of 100.000 suffer from this brain tumour. Traditional radiotherapy using hospital X-rays only has a palliative effect because gliomas are some of the most radio-resistant human tumours. Chemotherapy is ineffective most of the time. Several therapeutic techniques have been developed over the last years using animal models, but none has had such successful results as this new treatment with cis-platinum combined with monochromatic synchrotron x-rays. This new technique combines chemotherapy with radiotherapy in such a way that both techniques are effective when associated.


In this study, a drug called Cis-platinum was injected into the brain of rats bearing F98 glioma. The substance entered the DNAs of the tumour and limited the tumoral proliferation. A day later, at the Medical Beamline of the ESRF, the tumour was irradiated with X-rays of a very precise energy (monochromatic) The difference between these X-rays and the conventional X-ray sources used in hospitals is the brilliance: the beam produced by the ESRF synchrotron is a hundred thousand times brighter than the beam produced by a hospital X-ray machine, allowing the beam to be tuned at a convenient wavelength.

This in vivo experiment was preceded by in vitro experiments on cells using the same tumoral model (F98). This tumour is extremely radioresistant and it spreads very quickly. The mean survival time of untreated rats was 28 days. If cis-platinum was injected, they survived up to 39 days. If the rats were irradiated with X-rays at a certain wavelength, it could result in a maximum of 48 days of survival. The combination of both treatments, with a specific radiation dose and a specific X-ray wavelength appeared to be the most efficient treatment tested and offered a mean survival time of around 200 days. This means a 6-fold increase in the life span of treated rats compared to those which didn’t receive any treatment.

The success of the trials has led CHU and ESRF researchers to envisage the elaboration of a protocol in order to use these techniques on humans. “There is a lot of technological development to be carried out, but it is feasible”, explains Doctor François Estève, one of the authors of the paper. “The ESRF Medical Beamline is a unique place in the world where pre-clinical and clinical research in radiotherapy with synchrotron radiation is possible nowadays” says Doctor Alberto Bravin, responsible for the Medical Beamline. Rats and humans don’t have so much physical resemblance, so doctors and physicists still cannot say whether they would have the same outstanding results if humans were treated. But François Estève is convinced that “taking into account the impossibility nowadays of healing this brain tumour, it is really a must to try this method”.

Montserrat Capellas | alfa
Further information:
http://www.esrf.fr

More articles from Life Sciences:

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

nachricht Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>